- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00590889
Artificial Valve Endocarditis Reduction Trial (AVERT)
February 1, 2019 updated by: Abbott Medical Devices
The purpose of this study is to investigate whether the Silzone coated sewing cuff reduces the incidence of prosthetic valve endocarditis (PVE).
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to investigate whether the Silzone coated sewing cuff reduces the incidence of prosthetic valve endocarditis. The null and alternative hypotheses of this study are:
- Ho: Patients receiving SJM Masters Series valves with Silzone coating will have an equal incidence of PVE when compared to those receiving the conventional cuff.
- Ha: Patients receiving SJM Masters Series valves with Silzone coating will have a reduced incidence of PVE when compared to those receiving the conventional cuff.
Study Type
Interventional
Enrollment (Actual)
807
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alberta
-
Edmonton, Alberta, Canada
- University of Alberta Hospital
-
-
British Columbia
-
Vancouver, British Columbia, Canada
- University of British Columbia
-
-
-
-
-
Nantes, France
- Hopital G. Et R. Laennec
-
-
-
-
-
Berlin, Germany
- Deutches Herzzentrum Berlin
-
-
-
-
-
Milan, Italy
- Fond Ne Centro S. Raffaele
-
-
-
-
-
Nieuwegein, Netherlands
- St. Antonius Ziekenhuis
-
-
-
-
-
Madrid, Spain
- Hospital 12 de Octubre
-
-
-
-
-
Bern, Switzerland, CH-3010
- Inselspital
-
Sion, Switzerland
- Hopital Regional-Service de Cardiologie
-
-
-
-
Florida
-
Orlando, Florida, United States, 32803
- Florida Heart Group
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
Boston, Massachusetts, United States, 02115
- Brigham and Womens Hospital
-
-
Minnesota
-
Rochester, Minnesota, United States, 55902
- Mayo Clinic
-
-
Oregon
-
Portland, Oregon, United States, 97225
- Sisters of Providence Health System
-
-
Texas
-
Houston, Texas, United States, 77030
- Texas Heart Institute
-
-
Utah
-
Salt Lake City, Utah, United States, 84103
- LDS Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The patient requires an isolated mitral, isolated aortic, or double (aortic and mitral) valve replacement
- The patient is a candidate to receive an SJM (St. Jude Medical) Masters Series valve(s) with either the conventional cuff or the cuff with Silzone coating
- The patient (or legal guardian) has signed a study-specific consent form agreeing to the randomization, data collection, and follow-up requirements
Exclusion Criteria:
- The patient has a medical condition which contraindicates implantation of the SJM Masters Series with Silzone coating
- The patient already has a prosthetic valve other than the valve being replaced at this time
- The patient requires a tricuspid valve replacement
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: St. Jude Medical (SJM) Conventional
St. Jude Medical (SJM) Standard Masters Series Mechanical Heart Valve with Conventional Cuff
|
Both arms used market released mechanical heart valves in accordance with approved labeling
|
OTHER: St. Jude Medical (SJM) Silzone
St. Jude Medical (SJM) Masters Series Mechanical Heart Valve with Silzone Coating
|
Both arms used market released mechanical heart valves in accordance with approved labeling
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of Prosthetic Valve Endocarditis Comparing Conventional Valves to Silzone™ Coated Valves.
Time Frame: 1 year
|
Patient response to treatment with the Silzone™ treated valve will be evaluated based upon the incidence of early and late PVE (prosthetic valve endocarditis) in the treatment group vs. the control group.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Schaff H, Carrel T, Steckelberg JM, Grunkemeier GL, Holubkov R. Artificial Valve Endocarditis Reduction Trial (AVERT): protocol of a multicenter randomized trial. J Heart Valve Dis. 1999 Mar;8(2):131-9.
- Davila-Roman VG, Waggoner AD, Kennard ED, Holubkov R, Jamieson WR, Englberger L, Carrel TP, Schaff HV; Artificial Valve Endocarditis Reduction Trial echocardiography study. Prevalence and severity of paravalvular regurgitation in the Artificial Valve Endocarditis Reduction Trial (AVERT) echocardiography study. J Am Coll Cardiol. 2004 Oct 6;44(7):1467-72. doi: 10.1016/j.jacc.2003.12.060.
- Schaff HV, Carrel TP, Jamieson WR, Jones KW, Rufilanchas JJ, Cooley DA, Hetzer R, Stumpe F, Duveau D, Moseley P, van Boven WJ, Grunkemeier GL, Kennard ED, Holubkov R; Artificial Valve Endocarditis Reduction Trial. Paravalvular leak and other events in silzone-coated mechanical heart valves: a report from AVERT. Ann Thorac Surg. 2002 Mar;73(3):785-92. doi: 10.1016/s0003-4975(01)03442-7.
- Englberger L, Carrel T, Schaff HV, Kennard ED, Holubkov R; AVERT Investigators. Differences in heart valve procedures between North American and European centers: a report from the Artificial Valve Endocarditis Reduction Trial (AVERT). J Heart Valve Dis. 2001 Sep;10(5):562-71.
- Englberger L, Schaff HV, Jamieson WR, Kennard ED, Im KA, Holubkov R, Carrel TP; AVERT Investigators. Importance of implant technique on risk of major paravalvular leak (PVL) after St. Jude mechanical heart valve replacement: a report from the Artificial Valve Endocarditis Reduction Trial (AVERT). Eur J Cardiothorac Surg. 2005 Dec;28(6):838-43. doi: 10.1016/j.ejcts.2005.09.014. Epub 2005 Nov 7.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 1998
Primary Completion (ACTUAL)
September 1, 2014
Study Completion (ACTUAL)
September 1, 2014
Study Registration Dates
First Submitted
December 26, 2007
First Submitted That Met QC Criteria
January 10, 2008
First Posted (ESTIMATE)
January 11, 2008
Study Record Updates
Last Update Posted (ACTUAL)
February 27, 2019
Last Update Submitted That Met QC Criteria
February 1, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 979
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Valve Disease
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaTerminatedAortic Regurgitation | Aortic Valve Insufficiency | Regurgitation, Aortic Valve | Aortic Valve | Aortic IncompetenceKorea, Republic of
-
Genesis Medtech CorporationRecruiting
-
Assistance Publique Hopitaux De MarseilleSuspendedAortic Valve Regurgitation AcquiredFrance
-
The Cleveland ClinicRecruitingAortic Stenosis | Aortic Regurgitation | Valve Heart DiseaseUnited States
-
Na Homolce HospitalCentre of Cardiovascular and Transplantation Surgery, Czech Republic; St. Anne... and other collaboratorsRecruitingAortic Valve RegurgitationSerbia, Czechia, Belgium
-
Oslo University HospitalCompletedCoronary Artery Disease. | Aortic Valve Stenosis. | Aortic Valve Regurgitation.Norway
-
Han Yaling, MDRecruitingCardiac Rehabilitation | Valve Disease, AorticChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingAortic Regurgitation | Transcatheter Aortic Valve ReplacementChina
-
Fondazione Policlinico Universitario Agostino Gemelli...Enrolling by invitationAortic Valve Stenosis | Heart Valve Diseases | Aortic Regurgitation | Aortic Valve Insufficiency | Aortic Stenosis, Severe | Regurgitation, Aortic | Stenoses, Aortic | Coronary; Obstruction | Valve Disease, AorticItaly
-
UMC UtrechtTerminatedPeriprosthetic Aortic Valve Regurgitation After TAVINetherlands
Clinical Trials on Artificial Mechanical Heart Valve
-
Abbott Medical DevicesRecruitingAortic Valve Disease | Valvular Heart DiseaseChina
-
Abbott Medical DevicesActive, not recruitingMitral Valve Disease | Damaged Mitral Valve | Malfunctioning Mitral Heart Valve | Mitral Valve ReplacementUnited States
-
On-X Life Technologies, Inc.CompletedHeart Valve DiseaseUnited States, Canada, Netherlands, India, Australia, Germany, Norway, South Africa, Sweden
-
Medtronic Cardiac SurgeryRecruitingValve Disease, HeartUnited States, Belgium, Greece, Germany, Netherlands, Austria, France, Italy, Switzerland, Spain
-
Maria Cecilia HospitalEttore Sansavini Health Science FoundationCompletedAortic Valve SurgeryItaly
-
Kolding SygehusOdense University Hospital; Regionshospitalet Holstebro, Holstebro, DenmarkUnknownHeart Failure | Aortic Stenosis | Healthy Volunteers | Ischemic Heart Disease | Pulmonary HypertensionDenmark
-
Carmat SARecruitingAdvanced Heart FailureFrance
-
Edwards LifesciencesCompletedCoronary Artery Disease | Heart Failure | Aortic Valve Stenosis | Aortic Valve Insufficiency | Aortic Valve DisorderPoland
-
Nanjing First Hospital, Nanjing Medical UniversityRecruiting